Monoamine oxidase B (MAO-B), acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) are important targets for drugs used in the treatment of Alzheimer’s disease [113,114,115]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.